Intrinsic value of Becton Dickinson - BDX

Previous Close

$253.12

  Intrinsic Value

$144.80

stock screener

  Rating & Target

sell

-43%

Previous close

$253.12

 
Intrinsic value

$144.80

 
Up/down potential

-43%

 
Rating

sell

We calculate the intrinsic value of BDX stock by summing up the current values of future distributable cash flows generated by the company and dividing the sum by the number of outstanding shares. As such, the intrinsic value calculation depends entirely on projections. The more accurate your projections of the company's performance are - the more reliable is the intrinsic value calculation result. Please make sure to check the stock valuation input data below and adjust it if necessary. The quality of the output (intrinsic valuation result) is only as good as the quality of the input. See also DISCLAIMERS.

STOCK VALUATION INPUT DATA

Revenue (in 2017), $M
Initial revenue growth rate, %
Terminal revenue growth rate, %
Revenue decline factor
Initial discount rate, %
Discount rate multiplier
Variable cost ratio, %
Fixed operating expenses, $M
Interest rate on debt, %
Effective corporate tax rate, %
Production assets / Revenue, %
Life of production assets, yrs
Working capital / Revenue, %
Revenue / Adjusted assets
Adjusted equity ratio
Cash flow adjustment, % of Revenue
Book value of equity, $M
Shares outstanding, mln
Market capitalization, $bln 57.7

 

FINANCIAL STATEMENTS FORECAST and PRESENT VALUE CALCULATION

Fiscal year
   2018
   2019
   2020
   2021
   2022
   2023
   2024
   2025
   2026
   2027
   2028
   2029
   2030
   2031
   2032
   2033
   2034
   2035
   2036
   2037
   2038
   2039
   2040
   2041
   2042
   2043
   2044
   2045
   2046
   2047

INCOME STATEMENT

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Revenue growth rate, %
  2.00
  2.30
  2.57
  2.81
  3.03
  3.23
  3.41
  3.57
  3.71
  3.84
  3.95
  4.06
  4.15
  4.24
  4.31
  4.38
  4.44
  4.50
  4.55
  4.59
  4.64
  4.67
  4.70
  4.73
  4.76
  4.78
  4.81
  4.83
  4.84
  4.86
Revenue, $m
  12,335
  12,619
  12,943
  13,307
  13,710
  14,153
  14,635
  15,157
  15,719
  16,322
  16,967
  17,656
  18,389
  19,169
  19,995
  20,872
  21,799
  22,780
  23,817
  24,911
  26,066
  27,283
  28,567
  29,919
  31,344
  32,843
  34,422
  36,083
  37,830
  39,668
Variable operating expenses, $m
  10,889
  11,109
  11,360
  11,642
  11,954
  12,296
  12,669
  13,073
  13,508
  13,975
  13,128
  13,661
  14,228
  14,831
  15,471
  16,149
  16,867
  17,626
  18,428
  19,274
  20,168
  21,110
  22,103
  23,149
  24,251
  25,412
  26,633
  27,918
  29,270
  30,693
Fixed operating expenses, $m
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
Total operating expenses, $m
  10,889
  11,109
  11,360
  11,642
  11,954
  12,296
  12,669
  13,073
  13,508
  13,975
  13,128
  13,661
  14,228
  14,831
  15,471
  16,149
  16,867
  17,626
  18,428
  19,274
  20,168
  21,110
  22,103
  23,149
  24,251
  25,412
  26,633
  27,918
  29,270
  30,693
Operating income, $m
  1,445
  1,510
  1,583
  1,665
  1,757
  1,857
  1,966
  2,084
  2,211
  2,348
  3,839
  3,995
  4,161
  4,337
  4,524
  4,723
  4,933
  5,154
  5,389
  5,637
  5,898
  6,173
  6,464
  6,770
  7,092
  7,431
  7,789
  8,165
  8,560
  8,976
EBITDA, $m
  4,612
  4,718
  4,839
  4,975
  5,126
  5,291
  5,472
  5,667
  5,877
  6,102
  6,344
  6,601
  6,875
  7,167
  7,476
  7,803
  8,150
  8,517
  8,904
  9,313
  9,745
  10,200
  10,680
  11,186
  11,718
  12,279
  12,869
  13,490
  14,144
  14,831
Interest expense (income), $m
  435
  1,008
  1,013
  1,043
  1,078
  1,118
  1,161
  1,209
  1,261
  1,317
  1,378
  1,443
  1,513
  1,587
  1,667
  1,751
  1,840
  1,935
  2,035
  2,141
  2,253
  2,371
  2,496
  2,627
  2,766
  2,912
  3,066
  3,228
  3,398
  3,577
  3,766
Earnings before tax, $m
  437
  497
  540
  587
  639
  696
  757
  823
  894
  969
  2,396
  2,482
  2,574
  2,671
  2,774
  2,883
  2,998
  3,120
  3,248
  3,384
  3,527
  3,678
  3,837
  4,004
  4,180
  4,366
  4,561
  4,766
  4,982
  5,210
Tax expense, $m
  118
  134
  146
  158
  173
  188
  204
  222
  241
  262
  647
  670
  695
  721
  749
  778
  809
  842
  877
  914
  952
  993
  1,036
  1,081
  1,129
  1,179
  1,231
  1,287
  1,345
  1,407
Net income, $m
  319
  363
  394
  429
  466
  508
  552
  601
  652
  708
  1,749
  1,812
  1,879
  1,950
  2,025
  2,104
  2,188
  2,277
  2,371
  2,470
  2,575
  2,685
  2,801
  2,923
  3,052
  3,187
  3,330
  3,479
  3,637
  3,803

BALANCE SHEET

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Cash and short-term investments, $m
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
Total assets, $m
  27,411
  28,041
  28,762
  29,571
  30,467
  31,451
  32,522
  33,682
  34,931
  36,271
  37,706
  39,236
  40,865
  42,597
  44,434
  46,382
  48,443
  50,623
  52,926
  55,358
  57,924
  60,630
  63,482
  66,487
  69,653
  72,985
  76,493
  80,184
  84,067
  88,152
Adjusted assets (=assets-cash), $m
  27,411
  28,041
  28,762
  29,571
  30,467
  31,451
  32,522
  33,682
  34,931
  36,271
  37,706
  39,236
  40,865
  42,597
  44,434
  46,382
  48,443
  50,623
  52,926
  55,358
  57,924
  60,630
  63,482
  66,487
  69,653
  72,985
  76,493
  80,184
  84,067
  88,152
Revenue / Adjusted assets
  0.450
  0.450
  0.450
  0.450
  0.450
  0.450
  0.450
  0.450
  0.450
  0.450
  0.450
  0.450
  0.450
  0.450
  0.450
  0.450
  0.450
  0.450
  0.450
  0.450
  0.450
  0.450
  0.450
  0.450
  0.450
  0.450
  0.450
  0.450
  0.450
  0.450
Average production assets, $m
  18,206
  18,625
  19,104
  19,641
  20,237
  20,890
  21,601
  22,371
  23,201
  24,091
  25,044
  26,060
  27,143
  28,293
  29,513
  30,807
  32,176
  33,624
  35,153
  36,769
  38,473
  40,270
  42,165
  44,161
  46,263
  48,477
  50,807
  53,258
  55,838
  58,551
Working capital, $m
  -1,344
  -1,375
  -1,411
  -1,450
  -1,494
  -1,543
  -1,595
  -1,652
  -1,713
  -1,779
  -1,849
  -1,925
  -2,004
  -2,089
  -2,180
  -2,275
  -2,376
  -2,483
  -2,596
  -2,715
  -2,841
  -2,974
  -3,114
  -3,261
  -3,416
  -3,580
  -3,752
  -3,933
  -4,124
  -4,324
Total debt, $m
  18,754
  19,321
  19,970
  20,698
  21,505
  22,390
  23,354
  24,398
  25,522
  26,728
  28,019
  29,396
  30,863
  32,421
  34,075
  35,827
  37,683
  39,644
  41,717
  43,906
  46,215
  48,651
  51,218
  53,923
  56,771
  59,771
  62,928
  66,250
  69,745
  73,421
Total liabilities, $m
  24,670
  25,237
  25,886
  26,614
  27,421
  28,306
  29,270
  30,314
  31,438
  32,644
  33,935
  35,312
  36,779
  38,337
  39,991
  41,743
  43,599
  45,560
  47,633
  49,822
  52,131
  54,567
  57,134
  59,839
  62,687
  65,687
  68,844
  72,166
  75,661
  79,337
Total equity, $m
  2,741
  2,804
  2,876
  2,957
  3,047
  3,145
  3,252
  3,368
  3,493
  3,627
  3,771
  3,924
  4,087
  4,260
  4,443
  4,638
  4,844
  5,062
  5,293
  5,536
  5,792
  6,063
  6,348
  6,649
  6,965
  7,299
  7,649
  8,018
  8,407
  8,815
Total liabilities and equity, $m
  27,411
  28,041
  28,762
  29,571
  30,468
  31,451
  32,522
  33,682
  34,931
  36,271
  37,706
  39,236
  40,866
  42,597
  44,434
  46,381
  48,443
  50,622
  52,926
  55,358
  57,923
  60,630
  63,482
  66,488
  69,652
  72,986
  76,493
  80,184
  84,068
  88,152
Debt-to-equity ratio
  6.840
  6.890
  6.940
  7.000
  7.060
  7.120
  7.180
  7.240
  7.310
  7.370
  7.430
  7.490
  7.550
  7.610
  7.670
  7.720
  7.780
  7.830
  7.880
  7.930
  7.980
  8.020
  8.070
  8.110
  8.150
  8.190
  8.230
  8.260
  8.300
  8.330
Adjusted equity ratio
  0.100
  0.100
  0.100
  0.100
  0.100
  0.100
  0.100
  0.100
  0.100
  0.100
  0.100
  0.100
  0.100
  0.100
  0.100
  0.100
  0.100
  0.100
  0.100
  0.100
  0.100
  0.100
  0.100
  0.100
  0.100
  0.100
  0.100
  0.100
  0.100
  0.100

CASH FLOW

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Net income, $m
  319
  363
  394
  429
  466
  508
  552
  601
  652
  708
  1,749
  1,812
  1,879
  1,950
  2,025
  2,104
  2,188
  2,277
  2,371
  2,470
  2,575
  2,685
  2,801
  2,923
  3,052
  3,187
  3,330
  3,479
  3,637
  3,803
Depreciation, amort., depletion, $m
  3,166
  3,208
  3,256
  3,310
  3,369
  3,435
  3,506
  3,583
  3,666
  3,755
  2,504
  2,606
  2,714
  2,829
  2,951
  3,081
  3,218
  3,362
  3,515
  3,677
  3,847
  4,027
  4,216
  4,416
  4,626
  4,848
  5,081
  5,326
  5,584
  5,855
Funds from operations, $m
  3,486
  3,571
  3,650
  3,738
  3,836
  3,942
  4,058
  4,183
  4,318
  4,462
  4,253
  4,418
  4,593
  4,779
  4,976
  5,185
  5,406
  5,640
  5,887
  6,147
  6,422
  6,712
  7,017
  7,339
  7,678
  8,035
  8,410
  8,805
  9,221
  9,658
Change in working capital, $m
  -26
  -31
  -35
  -40
  -44
  -48
  -53
  -57
  -61
  -66
  -70
  -75
  -80
  -85
  -90
  -96
  -101
  -107
  -113
  -119
  -126
  -133
  -140
  -147
  -155
  -163
  -172
  -181
  -190
  -200
Cash from operations, $m
  3,512
  3,602
  3,685
  3,778
  3,880
  3,991
  4,111
  4,240
  4,379
  4,528
  4,324
  4,493
  4,673
  4,864
  5,066
  5,280
  5,507
  5,747
  5,999
  6,266
  6,548
  6,845
  7,157
  7,486
  7,833
  8,198
  8,582
  8,986
  9,411
  9,858
Maintenance CAPEX, $m
  -1,785
  -1,821
  -1,862
  -1,910
  -1,964
  -2,024
  -2,089
  -2,160
  -2,237
  -2,320
  -2,409
  -2,504
  -2,606
  -2,714
  -2,829
  -2,951
  -3,081
  -3,218
  -3,362
  -3,515
  -3,677
  -3,847
  -4,027
  -4,216
  -4,416
  -4,626
  -4,848
  -5,081
  -5,326
  -5,584
New CAPEX, $m
  -359
  -419
  -479
  -537
  -595
  -653
  -711
  -770
  -830
  -890
  -953
  -1,016
  -1,082
  -1,150
  -1,220
  -1,293
  -1,369
  -1,448
  -1,530
  -1,615
  -1,704
  -1,797
  -1,895
  -1,996
  -2,102
  -2,214
  -2,330
  -2,452
  -2,579
  -2,713
Cash from investing activities, $m
  -2,144
  -2,240
  -2,341
  -2,447
  -2,559
  -2,677
  -2,800
  -2,930
  -3,067
  -3,210
  -3,362
  -3,520
  -3,688
  -3,864
  -4,049
  -4,244
  -4,450
  -4,666
  -4,892
  -5,130
  -5,381
  -5,644
  -5,922
  -6,212
  -6,518
  -6,840
  -7,178
  -7,533
  -7,905
  -8,297
Free cash flow, $m
  1,368
  1,362
  1,344
  1,330
  1,320
  1,314
  1,310
  1,310
  1,313
  1,318
  962
  972
  985
  999
  1,016
  1,036
  1,057
  1,081
  1,107
  1,136
  1,167
  1,200
  1,236
  1,274
  1,315
  1,358
  1,405
  1,454
  1,506
  1,562
Issuance/(repayment) of debt, $m
  87
  567
  649
  728
  807
  885
  964
  1,044
  1,124
  1,206
  1,291
  1,377
  1,466
  1,558
  1,654
  1,753
  1,855
  1,962
  2,073
  2,189
  2,309
  2,435
  2,567
  2,705
  2,849
  2,999
  3,157
  3,322
  3,495
  3,676
Issuance/(repurchase) of shares, $m
  129
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
Cash from financing (excl. dividends), $m  
  216
  567
  649
  728
  807
  885
  964
  1,044
  1,124
  1,206
  1,291
  1,377
  1,466
  1,558
  1,654
  1,753
  1,855
  1,962
  2,073
  2,189
  2,309
  2,435
  2,567
  2,705
  2,849
  2,999
  3,157
  3,322
  3,495
  3,676
Total cash flow (excl. dividends), $m
  1,584
  1,930
  1,993
  2,058
  2,127
  2,199
  2,274
  2,354
  2,437
  2,524
  2,253
  2,349
  2,451
  2,558
  2,670
  2,788
  2,912
  3,043
  3,180
  3,324
  3,476
  3,635
  3,803
  3,979
  4,164
  4,358
  4,562
  4,776
  5,001
  5,238
Retained Cash Flow (-), $m
  -448
  -63
  -72
  -81
  -90
  -98
  -107
  -116
  -125
  -134
  -143
  -153
  -163
  -173
  -184
  -195
  -206
  -218
  -230
  -243
  -257
  -271
  -285
  -301
  -317
  -333
  -351
  -369
  -388
  -408
Prev. year cash balance distribution, $m
  10,655
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
Cash flow adjustment, $m
  254
  259
  265
  272
  279
  288
  297
  307
  318
  330
  343
  356
  371
  386
  403
  420
  438
  458
  478
  500
  523
  547
  573
  600
  628
  658
  690
  723
  758
  794
Cash available for distribution, $m
  11,791
  1,867
  1,921
  1,977
  2,037
  2,101
  2,167
  2,238
  2,312
  2,390
  2,109
  2,196
  2,288
  2,385
  2,486
  2,594
  2,706
  2,825
  2,950
  3,081
  3,219
  3,365
  3,518
  3,678
  3,847
  4,024
  4,211
  4,407
  4,613
  4,829
Discount rate, %
  4.30
  4.52
  4.74
  4.98
  5.23
  5.49
  5.76
  6.05
  6.35
  6.67
  7.00
  7.35
  7.72
  8.11
  8.51
  8.94
  9.39
  9.86
  10.35
  10.87
  11.41
  11.98
  12.58
  13.21
  13.87
  14.56
  15.29
  16.05
  16.86
  17.70
PV of cash for distribution, $m
  11,305
  1,709
  1,671
  1,628
  1,579
  1,524
  1,464
  1,399
  1,328
  1,253
  1,002
  937
  870
  801
  730
  659
  589
  520
  454
  392
  333
  279
  231
  187
  150
  117
  90
  68
  50
  36
Current shareholders' claim on cash, %
  98.8
  98.8
  98.8
  98.8
  98.8
  98.8
  98.8
  98.8
  98.8
  98.8
  98.8
  98.8
  98.8
  98.8
  98.8
  98.8
  98.8
  98.8
  98.8
  98.8
  98.8
  98.8
  98.8
  98.8
  98.8
  98.8
  98.8
  98.8
  98.8
  98.8

Becton, Dickinson and Company (BD) is a global medical technology company engaged in the development, manufacture and sale of a range of medical supplies, devices, laboratory equipment and diagnostic products. The Company operates through two segments: BD Medical and BD Life Sciences. The BD Medical segment produces an array of medical technologies and devices that are used to help improve healthcare delivery in a range of settings. BD Medical consists of various business units, including diabetes care, medication and procedural solutions, medication management solutions and pharmaceutical systems. The BD Life Sciences segment provides products for the safe collection and transport of diagnostics specimens, and instruments and reagent systems to detect a range of infectious diseases, healthcare-associated infections and cancers. The Company's BD Life Sciences segment consists of various business units, including preanalytical systems, diagnostic systems and biosciences.

FINANCIAL RATIOS  of  Becton Dickinson (BDX)

Valuation Ratios
P/E Ratio 52.5
Price to Sales 4.8
Price to Book 4.5
Price to Tangible Book
Price to Cash Flow 22.6
Price to Free Cash Flow 31.6
Growth Rates
Sales Growth Rate -3.1%
Sales - 3 Yr. Growth Rate %
EPS Growth Rate %
EPS - 3 Yr. Growth Rate %
Capital Spending Gr. Rate 1.3%
Cap. Spend. - 3 Yr. Gr. Rate 2.2%
Financial Strength
Quick Ratio 70
Current Ratio 0
LT Debt to Equity 144.2%
Total Debt to Equity 145.7%
Interest Coverage 3
Management Effectiveness
Return On Assets 5%
Ret/ On Assets - 3 Yr. Avg. 5.1%
Return On Total Capital 4.3%
Ret/ On T. Cap. - 3 Yr. Avg. 4.7%
Return On Equity 10.7%
Return On Equity - 3 Yr. Avg. 11.8%
Asset Turnover 0.4
Profitability Ratios
Gross Margin 49.1%
Gross Margin - 3 Yr. Avg. 47.6%
EBITDA Margin 20.7%
EBITDA Margin - 3 Yr. Avg. 20.1%
Operating Margin 11.6%
Oper. Margin - 3 Yr. Avg. 11.2%
Pre-Tax Margin 8.1%
Pre-Tax Margin - 3 Yr. Avg. 8%
Net Profit Margin 9.1%
Net Profit Margin - 3 Yr. Avg. 7.9%
Effective Tax Rate -12.7%
Eff/ Tax Rate - 3 Yr. Avg. 0.8%
Payout Ratio 61.5%

BDX stock valuation input parameters

Revenue. Company's revenue (or sales) is always the starting point of any cash flow forecast. In the BDX stock intrinsic value calculation we used $12093 million for the last fiscal year's total revenue generated by Becton Dickinson. The default revenue input number comes from 2017 income statement of Becton Dickinson. You may change it if you feel that it should be adjusted for some unusual circumstances that are not expected to be repeated in the future or if you already know (from interim financial statements, for example) that this year's revenue is going to be quite different.

Revenue growth rate. Forecasted future revenue growth rate is the most important input parameter for the intrinsic value calculation. Unlike other input parameters that are reasonably expected to be in line with their historic averages or their historic trends, the revenue growth rate by and large is a wild card: nobody really knows what the company's revenue will be in the future. Of course, the level of unpredictability is different for different industries (utility companies being the most predictable and, thus, less risky).
    We use three input parameters to forecast the revenue growth rate in our BDX stock valuation model: a) initial revenue growth rate of 2% whose default value is the revenue growth rate in the most recent quarter compared to the quarterly revenue a year ago; b) terminal revenue growth rate of 5% whose default value is chosen to be close to the average nominal (i.e. not adjusted for inflation) GDP growth rate; and c) revenue decline factor of 0.9, which stipulates that revenue growth rate in each forecasted year will be equal to the difference of the revenue growth rate in the preceding year and the terminal revenue growth rate multiplied by this revenue decline factor (with the passage of time the revenue growth rate will be approaching the terminal revenue growth rate, but not quite reaching it - though the difference could be infinitesimally small).
    At the revenue decline factor of 1, the future revenue growth rate is forecasted to be constant and equal to the initial revenue growth rate. The smaller the revenue decline factor, the faster the revenue growth rate will approach the terminal revenue growth.

Discount rate. The discount rate is used for determining the present value of future cash flows: future cash flows are "discounted" as at normal conditions (that translate into positive expected return on investment) one dollar today is worth more than the same dollar in the future. Unlike all other valuation models, we use variable discount rate, i.e. it increases for each consecutive year. This is done to account for higher risk of cash flows coming in further in the future.
    The initial discount rate of 4.3%, whose default value for BDX is calculated based on our internal credit rating of Becton Dickinson, is applied to the cash flow expected to be received a year from now (well, actually, to be precise, in the financial year following the base year - the last year for which we have financial statements). For each consecutive year the discount rate is multiplied by the discount rate multiplier of 1.05, e.i. each year it increases by 5%. Feel free to change this number to correspond to your level of risk assessment of Becton Dickinson.
    By the way, it is easy to set the discount rate to be constant (this would make comparison with other valuation models easier): just set the discount rate multiplier equal to 1 and chose the magnitude of the initial discount rate to your liking.

Variable cost ratio is the ratio of variable costs (i.e. costs that fluctuate with fluctuation of the volume of production) to the revenue expressed as a percentage. In the calculation of intrinsic value of BDX stock the variable cost ratio is equal to 88.5%.

Fixed operating expenses is just that - expenses that are not dependant on the volume of production. They are set to $0 million in the base year in the intrinsic value calculation for BDX stock. These expenses increase with the level of inflation in subsequent years.

Interest rate on debt is the average all-in rate of interest paid by the company on its debt. It is set at 5.4% for Becton Dickinson.

Corporate tax rate of 27% is the nominal tax rate for Becton Dickinson. In reality, companies find ways to pay much less taxes than that or not to pay them at all.

Cash flow adjustment could be used for any adjustment the investor deems necessary. Most commonly we use this field to account for stock options-related effects in excess of what is reported on the company's income statement. The cash flow adjustment is expressed as a percentage of the revenue, and in the current valuation of the BDX stock is equal to 2.1%.

Production assets are the company's assets used for manufacturing products or provision of services. In the valuation model input table they are expressed as a percentage of revenue and for BDX are equal to 147.6%.

Life of production assets of 10 years is the average useful life of capital assets used in Becton Dickinson operations. It is used to calculate yearly capital expenditures needed to keep these assets in good order - we call it the maintenance CAPEX.

Working capital is the difference between the company's current assets and liabilities. In the model we use the ratio of working capital to revenue, which for BDX is equal to -10.9%. A negative number means that the company is apt at using financial resources of its suppliers and customers; a large positive number, on the other hand, means that it either provides in-kind financing to others or is not good at managing its inventories.

Book value of equity - $12948 million for Becton Dickinson - is used in calculation of the "floor" for intrinsic valuation based on the discounted cash flow (DCF) method. Even if the prospects are very bad for a company, its assets could always be sold now for their current fair market value.

Shares outstanding of 228 million for Becton Dickinson is needed to calculate the intrinsic value of one share.

Market capitalization is used here only for reference purposes and as a quick check that the share price and the number of shares outstanding numbers are correct - something especially to be cognizant about at stock splits. So, the market capitalization of Becton Dickinson at the current share price and the inputted number of shares is $57.7 billion.

RELATED COMPANIES Price Int.Val. Rating
TMO Thermo Fisher 230.00 95.38  str.sell
TFX Teleflex 238.15 134.23  sell
HOLX Hologic 38.33 22.04  sell
BIO Bio-Rad Labora 316.56 51.35  str.sell
HYH Halyard Health 57.25 1.60  str.sell
RVP Retractable Te 0.730 1.54  str.buy

COMPANY NEWS

▶ BD Elects Jeffrey Henderson to Board of Directors   [Aug-16-18 06:59AM  PR Newswire]
▶ Becton Dickinson: Fiscal 3Q Earnings Snapshot   [06:14AM  Associated Press]
▶ Earnings Outlook For Becton Dickinson   [Aug-01-18 03:13PM  Benzinga]
▶ BD Board Declares Dividends   [Jul-24-18 04:30PM  PR Newswire]
▶ Amazon fuels T. Rowe Price U.S. mutual funds past the S&P 500   [Jul-23-18 08:57AM  American City Business Journals]
▶ Tempe lands first tenant for I.D.E.A. development   [03:00AM  American City Business Journals]
▶ BD to Present at Investor Healthcare Conferences   [Jun-01-18 04:30PM  PR Newswire]
▶ Becton Dickinson: Fiscal 2Q Earnings Snapshot   [06:10AM  Associated Press]
▶ BD Names Three Executives to Segment Leadership Roles   [Apr-27-18 06:59AM  PR Newswire]
▶ BD Board Declares Dividends   [Apr-23-18 04:30PM  PR Newswire]
▶ [$$] Apax Buying Remaining Stake in Vyaire Medical for $435 Million   [Mar-19-18 04:57PM  The Wall Street Journal]
▶ Amazon Could Enter Hospital Supply Chain Why Medtech Shouldn't Worry   [Feb-13-18 04:15PM  Investor's Business Daily]
Follow us on:   twitter   twitter   twitter   twitter

ASSET ALLOCATION

About X-FIN       Site news       Privacy policy       Terms of use       FAQ

Copyright © X-FIN.com 2005-2018. All rigths reserved.